Medication info
Januglu Tablets 100 Milligrams (Sitagliptin Hydrochloride Hydrate)

Januglu Tablets 100 Milligrams (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.37mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
Bright yellow-orange round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202301962 · Approved 2023.06.27 · Insurance code 651206050

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this medication, whether used as monotherapy or in combination therapy, is 100 mg once daily. The maximum daily dose is 100 mg. This medication may be taken with or without food. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is necessary, assessment of renal function before treatment and periodically thereafter is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. For patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. For patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medication may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be administered as monotherapy when blood sugar is not adequately controlled with diet and exercise alone. Additionally, if there is no previous experience with diabetes treatment and it is difficult to control blood sugar with monotherapy, it can be used in conjunction with metformin. It can also be administered alongside sulfonylureas, metformin, thiazolidinediones, and insulin when these monotherapies do not provide sufficient blood sugar control. Moreover, this medication can be added to the treatment when blood sugar control is challenging despite the use of multiple medications. Therefore, this medication effectively improves blood sugar control in type 2 diabetes.

Dosage and Administration

Adult dosage

The recommended dose of this medication, whether used as monotherapy or in combination therapy, is 100 mg once daily. The maximum daily dose is 100 mg. This medication may be taken with or without food. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is necessary, assessment of renal function before treatment and periodically thereafter is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. For patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. For patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medication may be administered without regard to the timing of dialysis.

Precautions

This medication may cause severe allergic reactions after administration; therefore, if symptoms of allergy or skin abnormalities appear, it should be discontinued immediately, and a physician should be consulted. Acute pancreatitis symptoms may occur, so if symptoms such as abdominal pain or vomiting arise, it is important to promptly inform healthcare personnel. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor in case of allergy to this medication or any of its components. Patients with impaired renal function should have their dosage adjusted, and they should take the medication following kidney function tests and the physician’s guidance. During treatment with this medication, symptoms similar to a cold, headaches, gastrointestinal symptoms, etc., may occur, so caution is needed. When taken with insulin or sulfonylureas, the risk of hypoglycemia may increase; therefore, regular checks of blood sugar levels and adjustments to medication dosage should be carried out as necessary. Severe joint pain or the appearance of skin blisters may be side effects of this medication, and prompt communication with a doctor is required; if symptoms are severe, discontinuation of the medication may be necessary. Pregnant or breastfeeding women are advised not to take this medication; there is insufficient evidence of safety and efficacy in children, so caution is warranted in their use. In cases of overdose, immediate medical attention is needed, and this medication can be partially removed by hemodialysis. It is important to regularly monitor kidney function and blood sugar levels while taking this medication, and consult with a physician regarding potential interactions with other medications.

Side effects

Severe hypersensitivity reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, upper respiratory infections, rhinitis, headache, diarrhea, abdominal pain, nausea, peripheral edema, constipation, vomiting, severe arthralgia accompanied by disability, blistering dermatitis, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased serum triglycerides, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is best kept at room temperature between 1 and 30 degrees Celsius. By maintaining proper temperature and environment, the effectiveness of the medication can be preserved.

Appearance and packaging

Appearance

Bright yellow-orange round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.